A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma

被引:56
作者
Christin-Maitre, S
Rongières-Bertrand, C
Kottler, ML
Lahlou, N
Frydman, R
Touraine, P
Bouchard, P
机构
[1] Hop St Antoine, Serv Endocrinol, Assistance Publ Hop Paris, F-75571 Paris 12, France
[2] Hop La Pitie Salpetriere, Lab Biochim Med, Assistance Publ Hop Paris, Paris, France
[3] Univ Paris 06, CNRS, URA 1449, Paris, France
[4] Hop St Vincent de Paul, INSERM U342, F-75674 Paris, France
[5] Hop Necker Enfants Malad, INSERM U344, Paris, France
[6] Hop Antoine Beclere, Serv Gynecol Obstet, Clamart, France
关键词
D O I
10.1210/jc.83.10.3450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report an unusual case of a gonadotroph adenoma in a 34-yr-old woman, revealed by a dramatic rise in the plasma estradiol (E-2) concentration (26,800 pmol/L; normal, <370), with nonsuppressed FSH and LH levels (4.9 and 2.4 mIU/mL, respectively). The PRL level was,503 ng/mL. The testosterone and progesterone levels were 7 and 17 nmol/L, respectively. The levels of inhibin alpha, inhibin A, and inhibin B were increased compared to normal values in both the follicular (fp) and luteal (Ip) phases of the menstrual cycle [inhibin alpha 1986 IU/L (fp normal, <700; Ip normal, <1650); inhibin A, 254 pg/mL (fp normal, <20; Ip normal, <120); inhibin B, 246 pg/mL (fp normal, <150; Ip normal, <30 Ip)]. Pituitary magnetic resonance imaging revealed a huge pituitary adenoma. After transphenoidal surgery, the patient presented with pituitary insufficiency and diabetes: insipidus. RT-PCR of the tumor tissue was positive for LH beta, FSH beta, alpha-subunit, and PRL. This case is of particular interest because 1) although the E-2 level was extremely high, the patient did not present with ascitis, suggesting that chronic elevated E-2 does not play a crucial role in the hyperstimulation symptoms; 2) the extreme rise in E-2 was related to the cosecretion of FSH and LH, confirming the two-cell two-gonadotrophin theory; and 3) tthee rise in inhibin B is associated with FSH secretion, whereas the rise in inhibin A is probably due to luteinization.
引用
收藏
页码:3450 / 3453
页数:4
相关论文
共 22 条
[1]   DOPAMINE AGONISTS AND PITUITARY-TUMOR SHRINKAGE [J].
BEVAN, JS ;
WEBSTER, J ;
BURKE, CW ;
SCANLON, MF .
ENDOCRINE REVIEWS, 1992, 13 (02) :220-240
[2]   PITUITARY APOPLEXY CAUSED BY GNRH-AGONIST TREATMENT REVEALING GONADOTROPH ADENOMA [J].
CHANSON, P ;
SCHAISON, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2267-2268
[3]   RESPONSES TO GONADOTROPIN-RELEASING-HORMONE AGONIST AND ANTAGONIST ADMINISTRATION IN PATIENTS WITH GONADOTROPH CELL ADENOMAS [J].
CHANSON, P ;
LAHLOU, N ;
WARNET, A ;
ROGER, M ;
SASSOLAS, G ;
LUBETZI, J ;
SCHAISON, G ;
BOUCHARD, P .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (02) :91-98
[4]   SIMILAR ISOELECTRIC PROFILES OF FSH FROM GONADOTROPH CELL ADENOMAS AND NON-ADENOMATOUS PITUITARIES [J].
CHAPPEL, SC ;
BASHEY, HM ;
SNYDER, PJ .
ACTA ENDOCRINOLOGICA, 1986, 113 (03) :311-316
[5]   Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle [J].
ChristinMaitre, S ;
Taylor, AE ;
Khoury, RH ;
Hall, JE ;
Martin, KA ;
Smith, PC ;
Albanese, C ;
Jameson, JL ;
Crowley, WF ;
Sluss, PM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2080-2088
[6]   EFFECTS OF LONG-TERM TREATMENT WITH THE GONADOTROPIN-RELEASING-HORMONE ANALOG NAFARELIN IN PATIENTS WITH NONFUNCTIONING PITUITARY-ADENOMAS [J].
COLOMBO, P ;
AMBROSI, B ;
SACCOMANNO, K ;
BASSETTI, M ;
CORTELAZZI, D ;
FAGLIA, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (04) :339-345
[7]   GONADOTROPH ADENOMA IN A PREMENOPAUSAL WOMAN SECRETING FOLLICLE-STIMULATING-HORMONE AND CAUSING OVARIAN HYPERSTIMULATION [J].
DJERASSI, A ;
COUTIFARIS, C ;
WEST, VA ;
ASA, SL ;
KAPOOR, SC ;
PAVLOU, SN ;
SNYDER, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02) :591-594
[8]  
FIDDES J C, 1981, Journal of Molecular and Applied Genetics, V1, P3
[9]  
FRANKS S, 1977, LANCET, V1, P778
[10]   DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY [J].
GROOME, NP ;
ILLINGWORTH, PJ ;
OBRIEN, M ;
COOKE, I ;
GANESAN, TS ;
BAIRD, DT ;
MCNEILLY, AS .
CLINICAL ENDOCRINOLOGY, 1994, 40 (06) :717-723